Search Results

pharmacology and molecular docking Published date October 28, 2024 Abstract "G Protein-Coupled Receptors Integrated approach combined network pharmacology and molecular docking to identify and validate the underlying pharmacological mechanisms. Subsequently, we established a protein-protein interaction (PPI) network by mapping the shared targets pharmacology Source Contribute to the GPCR News Coming soon Become a Contributor Classified GPCR News

Their network analysis uncovered significant clusters, emphasizing the interconnectedness of the S1P Network pharmacology analysis identified six herbal compounds-ampelopsin, ellagic acid, colchicine, epigallocatechin

Database-driven data mining and networking were utilized to establish a general correlation between Jinqiancao An experiment-based network reflected a pharmacological relationship between Jinqiancao granules and Xinmiao Liang Tags Benign prostatic hyperplasia , G-protein coupled receptor , Jinqiancao granules , Network pharmacology , Prostatitis Source Contribute to the GPCR News Coming soon Become a Contributor Classified

Soon About Louis Gendron "Dr Louis Gendron, PhD is tenured Professor and Chair of the Department of Pharmacology-Physiology He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers Dr Gendron is co-director of the FRQS-funded Quebec Pain Research Network and the Editor-in-Chief in

Committee Sponsors GPCR Retreat Program < Back to schedule Using food perception and bioamine signaling networks

Advanced data analysis for GPCR pharmacology Dr. Understanding the pharmacology data analysis framework we use for GPCRs. Module 2 - Quantifying agonist pharmacology and biased agonism. Module 3 - Antagonist pharmacology and binding assay analysis. Samuel Hoare Sam Hoare is a pharmacology data analyst with 30 years experience in GPCR pharmacology.

Applying Pharmacology to Drug Discovery Dr. Pharmacology is a unique discipline and is critical to drug discovery. What makes each drug type unique to therapeutic pharmacology? 3. Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta,

< GPCR News < GPCRs in Oncology and Immunology Biochemical pharmacology of adenylyl cyclases in cancer Published date October 1, 2024 Abstract "Globally, despite extensive research and pharmacological advancement

Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor Pharmacology Robert and his lab have been interested in the molecular pharmacology of cannabinoids for nearly 10 years

< GPCR News < GPCRs in Oncology and Immunology GPR56 signaling pathway network and its dynamics in the

Principles of Pharmacology in Drug Discovery I Dr. In general, registrants will receive a comprehensive understanding of the unique science of pharmacology Registrants will learn: Essentials of measuring pharmacologic activity of ligands (affinity, efficacy Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

Principles of Pharmacology in Drug Discovery II Dr. Modules Lecture 1: The Eyes to See- The Importance of Pharmacologic Assays. Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, then moved to the University of North Carolina School of Medicine where currently I am a Professor of Pharmacology My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

Graciela Pineyro is a professor of pharmacology at the department of pharmacology and physiology of the She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain.

Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological

He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class Today, Sam is a pharmacology data analyst and the founder of Pharmechanics LLC , a consultancy and data in vitro pharmacology data to advance drug discovery. Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences Sam is known for demystifying complicated and newly-emerging pharmacology concepts, enabling them to

Together with Ines Liebscher, Simone is leading an EU-funded COST Network on Adhesion GPCRs: CA18240 Being faced with the vast unknown biochemical and pharmacological territory that would be helpful to Together with Simone Prömel, Ines is leading a COST Network on adhesion GPCRs: CA18240 Adher'nRise.

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable

obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry received his Ph.D. in Pharmacology Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr. Terry Kenakin on the web LinkedIn UNC Department of Pharmacology Amazon ResearchGate Pubmed . Dr.

The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide For more information on the ERNEST network, visit https://ernest-gpcr.eu/ . Dr.

Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council He is a 2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification, and a member of the Faculty of 1000 (Molecular Pharmacology division) and an elected Fellow of the British Pharmacological Society (BPS).

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to

Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins ), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology